Outcome and prognostic factors of children with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib followed by allogeneic hematopoietic cell transplantation in first remission

BACKGROUND: Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is a subset of ALL with poor prognosis. Here, we analyzed the outcomes and prognostic factors of children with Ph+ ALL who received imatinib and chemotherapy followed by allogeneic hematopoietic cell transplantation...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Res
Egile Nagusiak: Shin, Juae, Lee, Na Yeong, Kim, Seongkoo, Lee, Jae Wook, Jang, Pil-Sang, Chung, Nack-Gyun, Cho, Bin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6439289/
https://ncbi.nlm.nih.gov/pubmed/30956963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2019.54.1.45
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak